[HTML][HTML] Baricitinib restrains the immune dysregulation in patients with severe COVID-19
…, V Petrova, F Hofer, RM Barouni… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Patients with coronavirus disease 2019 (COVID-19) develop pneumonia
generally associated with lymphopenia and a severe inflammatory response due to …
generally associated with lymphopenia and a severe inflammatory response due to …
Platelets promote thromboinflammation in SARS-CoV-2 pneumonia
…, E Carrara, V Petrova, RM Barouni… - … and Vascular Biology, 2020 - Am Heart Assoc
Objective: Pulmonary thrombosis is observed in severe acute respiratory syndrome
coronavirus 2 pneumonia. Aim was to investigate whether subpopulations of platelets were …
coronavirus 2 pneumonia. Aim was to investigate whether subpopulations of platelets were …
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy
S Canè, RM Barouni, M Fabbi, J Cuozzo… - Science Translational …, 2023 - science.org
Myeloid cells can restrain antitumor immunity by metabolic pathways, such as the degradation
of l-arginine, whose concentrations are regulated by the arginase 1 (ARG1) enzyme. …
of l-arginine, whose concentrations are regulated by the arginase 1 (ARG1) enzyme. …
[HTML][HTML] Deciphering the state of immune silence in fatal COVID-19 patients
…, D Eyal, A Fiore, C Anselmi, RM Barouni… - Nature …, 2021 - nature.com
Since the beginning of the SARS-CoV-2 pandemic, COVID-19 appeared as a unique
disease with unconventional tissue and systemic immune features. Here we show a COVID-19 …
disease with unconventional tissue and systemic immune features. Here we show a COVID-19 …
[HTML][HTML] Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells
…, A Hatzioannou, K Mintzas, RM Barouni… - The Journal of …, 2018 - Am Soc Clin Investig
Myeloid-derived suppressor cells (MDSCs) densely accumulate into tumors and potently
suppress antitumor immune responses, promoting tumor development. Targeting MDSCs in …
suppress antitumor immune responses, promoting tumor development. Targeting MDSCs in …
[HTML][HTML] Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis
…, S Cane, A Adamo, F Hofer, RM Barouni… - Cell Death & …, 2022 - nature.com
Inflammatory responses rapidly detect pathogen invasion and mount a regulated reaction.
However, dysregulated anti-pathogen immune responses can provoke life-threatening …
However, dysregulated anti-pathogen immune responses can provoke life-threatening …
[HTML][HTML] Charting granulopoietic disturbances in sepsis
RM Barouni, R Ostuni - Nature Immunology, 2023 - nature.com
… Roza Maria Barouni & Renato Ostuni … Roza Maria Barouni & Renato Ostuni … Roza
Maria Barouni …
Maria Barouni …
Phenotypical Characterization and Isolation of Tumor-Derived Mouse Myeloid-Derived Suppressor Cells
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population composed
of mature and immature cells of myeloid origin that play a major role in tumor progression by …
of mature and immature cells of myeloid origin that play a major role in tumor progression by …
Deciphering the state of immune silence in fatal COVID-19 patients (preprint)
…, M Castellucci, D Eyal, A Fiore, C Anselmi, RM Barouni… - 2020 - pesquisa.bvsalud.org
Since the beginning of the SARS-CoV-2 pandemic, COVID-19 has appeared as a unique
disease with unconventional tissue and systemic immune features. While COVID-19 severe …
disease with unconventional tissue and systemic immune features. While COVID-19 severe …
Baricitinib restrains the immune dysregulation in COVID-19 patients (preprint)
…, R Trovato, A Fiore, V Petrova, F Hofer, RM Barouni… - 2020 - pesquisa.bvsalud.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the ongoing pandemic coronavirus disease 2019 (COVID-19). The majority of patients with …
the ongoing pandemic coronavirus disease 2019 (COVID-19). The majority of patients with …
